Type 2 Diabetes Mellitus Completed Phase 1 Trials for Insulin aspart (DB01306)

Also known as: T2DM / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Type Two / Type Two Diabetes Mellitus / NIDDM / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus Non-insulin-dependent / Type 2 Diabetes / Diabetes, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Type 2 Diabetes (T2D) / Diabetes Mellitus´╝îType 2 / Diabetes Mellitus. Type 2 / Diabetes Mellitus Type 2 / Diabetes Mellitus Type-2 / Type-2 Diabetes Mellitus / Diabetes Mellitus 2 Type / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus, Type 2 (T2DM) / T2DM (Type 2 Diabetes Mellitus) / Type 2 Diabetes Mellitus (T2D) / Diabetes Mellitus, Type 2 / Type-2 Diabetes / Diabetes Type 2 / Type 2 Diabetes (T2DM) / Type II Diabetes / Diabetes, Type II / Type-II Diabetes Mellitus / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / Diabetes Type II / Type II; Diabetes / Diabetes Mellitus Type II / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01159353Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin AspartTreatment
NCT02933853A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes MellitusTreatment
NCT01865305Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With DiabetesTreatment
NCT01620424Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 DiabetesTreatment
NCT01538511Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy VolunteersTreatment
NCT01527630Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese SubjectsTreatment
NCT01134224A Trial Investigating the Effect of NN5401 in Subjects With Type 2 DiabetesTreatment
NCT01121276A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 DiabetesTreatment
NCT01028404A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 DiabetesTreatment
NCT00825253Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 DiabetesTreatment
NCT00824668Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesTreatment
NCT00184613Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 DiabetesTreatment
NCT00115973A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion PumpTreatment